| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
,
* Program of Inflammatory Disease Research, Infectious and Inflammatory Disease Center, and
Program of Signal Transduction, Cancer Center, The Burnham Institute, La Jolla, CA 92037; and
Division of Biological Sciences Graduate Program, University of California-San Diego, La Jolla, CA 92093
Complement C3 cleavage products mediate the recognition and clearance of toxic or infectious agents. In addition, binding of the C3d fragment to Ag promotes B lymphocyte activation through coengagment of the BCR and complement receptor 2 (CD21). Signal augmentation is thought to be achieved through enhanced recruitment and activation of CD21-associated CD19. In this study we show, using the DBA/1 collagen-induced arthritis (CIA) model, that conjugation of C3d to heterologous type II collagen is sufficient to cause disease in the absence of the mycobacterial components of CFA. Transient depletion of C3 during the inductive phase of CIA delays and lessens the severity of disease, and DBA/1 mice deficient for coreceptor components CD19 or CD21 are not susceptible to CIA. Adoptive transfer experiments revealed that CD21 expression on either B cells or follicular dendritic cells is sufficient to acquire disease susceptibility. Although CD19–/– and CD21–/– mice produce primary Ab responses to heterologous and autologous type II collagen, they are impaired in the ability to activate T cells, form germinal centers, and produce secondary autoantibody responses. These findings indicate that binding of C3d to self-Ags can promote autoimmunity through enhanced Ag retention and presentation by follicular dendritic cells and B cells, respectively.
This article has been cited by other articles:
|
|
 |
|
  K. E. Nilsson, M. Andren, T. D. de Stahl, and S. Kleinau Enhanced susceptibility to low-dose collagen-induced arthritis in CR1/2-deficient female mice--possible role of estrogen on CR1 expression FASEB J, August 1, 2009; 23(8): 2450 - 2458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A M Blom, K S Nandakumar, and R Holmdahl C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice Ann Rheum Dis, January 1, 2009; 68(1): 136 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Song, F. Qiao, C. Atkinson, V. M. Holers, and S. Tomlinson A Complement C3 Inhibitor Specifically Targeted to Sites of Complement Activation Effectively Ameliorates Collagen-Induced Arthritis in DBA/1J Mice J. Immunol., December 1, 2007; 179(11): 7860 - 7867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Lyubchenko, J. M. Dal Porto, V. M. Holers, and J. C. Cambier Cutting Edge: Complement (C3d)-Linked Antigens Break B Cell Anergy J. Immunol., September 1, 2007; 179(5): 2695 - 2699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Morrison, R. J. Fraser, P. N. Smith, S. Mahalingam, and M. T. Heise Complement Contributes to Inflammatory Tissue Destruction in a Mouse Model of Ross River Virus-Induced Disease J. Virol., May 15, 2007; 81(10): 5132 - 5143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wu, S. A. Boackle, P. Hanvivadhanakul, D. Ulgiati, J. M. Grossman, Y. Lee, N. Shen, L. J. Abraham, T. R. Mercer, E. Park, et al. Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus PNAS, March 6, 2007; 104(10): 3961 - 3966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-F. Jegou, P. Chan, M.-T. Schouft, M. R. Griffiths, J. W. Neal, P. Gasque, H. Vaudry, and M. Fontaine C3d Binding to the Myelin Oligodendrocyte Glycoprotein Results in an Exacerbated Experimental Autoimmune Encephalomyelitis J. Immunol., March 1, 2007; 178(5): 3323 - 3331. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
